ERA: Complying with MiFID II – a Practical Guide to Implementation
Date
08 Mar 2018 to 09 Mar 2018
Address
Europäische Rechtsakademie (ERA)
Metzer Alee 4
54295 Trier
GermanyLinks
Event Description
Area of law:
Banking and Financial Services Law
Objective
This seminar will show legal practitioners how to comply with the most challenging aspects of MiFID II such as reporting requirements, creation of transaction reports, cost transparency, the Systemic Internaliser regime, rules on the use of new trading platforms and FinTech. Using practical examples, it will demonstrate how to deal with issues of product manufacturing, distribution, governance and best execution.
Key topics
- Hot issues with pre- and post-trade compliance
- Systematic Internaliser
- Post-trade issues
- Algorithmic and high-frequency trading (HFT), multilateral trading facility (MTF) and organised trading facility (OTF): the main points to consider
- Investor protection aspects of MiFID II
- Practical advice: how to comply with and how to avoid getting caught in breach of MiFID II’s requirements
Who should attend?Compliance officers, banking and capital markets lawyers, national supervisors.
Apply for a scholarship:The German Bundesbank Mainz has generously offered to sponsor the participation of a number of legal practitioners.
- Information for applicants
- Application form (Please send it to Joanna Kuzaj)
Events of the week
Jobs
HYDROGEN EUROPE
European Institute of Peace
Strago Healthcare
Eurocities
Strago Healthcare
PAX CHRISTI International
Pax Christi International
European Cyclists Federation
HYDROGEN EUROPE
Europe MédiaLab
EURACTIV News
- Climate friendly Paris Olympic Games focused on low carbon, repurposed construction [Advocacy Lab Content]
- Oliver Röpke’s big tent approach in his first year as EESC president [Advocacy Lab Content]
- European Medicines Agency makes recommendations to improve supply of critical medicines
- Paris Olympic Village getting climate fit for 2050 [Advocacy Lab Content]
- Polish patient education needed to boost clinical trial success [Advocacy Lab Content]